Cargando…

Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review

Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare variant of the inflammatory myofibroblastic tumor, characterized by more aggressive clinical course and nuclear membrane staining of anaplastic lymphoma kinase (ALK) with ALK rearrangement. An elderly male came to the clinic because o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dou, Weidong, Guan, Yu, Liu, Tao, Zheng, Hang, Feng, Shuo, Wu, Yingchao, Wang, Xin, Liu, Zhanbing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571703/
https://www.ncbi.nlm.nih.gov/pubmed/37841422
http://dx.doi.org/10.3389/fonc.2023.1212529
_version_ 1785120063321276416
author Dou, Weidong
Guan, Yu
Liu, Tao
Zheng, Hang
Feng, Shuo
Wu, Yingchao
Wang, Xin
Liu, Zhanbing
author_facet Dou, Weidong
Guan, Yu
Liu, Tao
Zheng, Hang
Feng, Shuo
Wu, Yingchao
Wang, Xin
Liu, Zhanbing
author_sort Dou, Weidong
collection PubMed
description Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare variant of the inflammatory myofibroblastic tumor, characterized by more aggressive clinical course and nuclear membrane staining of anaplastic lymphoma kinase (ALK) with ALK rearrangement. An elderly male came to the clinic because of an accidental abdominal mass. Abdominal and pelvic enhanced CT revealed a tumor apparently orginated from mesenchymal tissue. Subsequently, the abdominal mass and multiple organ resection was performed, and the mass was pathologically confirmed as EIMS. The patient developed Clavien-Dindo Grade III postoperative complications and was discharged after his condition improved. He received doxorubicin monotherapy after operation, but only one cycle was administered due to severe vomiting. The follow-up of 5 months after operation showed no evidence of recurrence. Given the rarity of EIMS, and ALk inhibitors have a long and robust effect on patients with ALK gene tumors, it is very important for clinicians to be familiar with the clinicopathological features of EIMS, which will contribute to the accurate diagnosis of EIMS and reduce misdiagnosis.
format Online
Article
Text
id pubmed-10571703
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-105717032023-10-14 Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review Dou, Weidong Guan, Yu Liu, Tao Zheng, Hang Feng, Shuo Wu, Yingchao Wang, Xin Liu, Zhanbing Front Oncol Oncology Epithelioid inflammatory myofibroblastic sarcoma (EIMS) is a rare variant of the inflammatory myofibroblastic tumor, characterized by more aggressive clinical course and nuclear membrane staining of anaplastic lymphoma kinase (ALK) with ALK rearrangement. An elderly male came to the clinic because of an accidental abdominal mass. Abdominal and pelvic enhanced CT revealed a tumor apparently orginated from mesenchymal tissue. Subsequently, the abdominal mass and multiple organ resection was performed, and the mass was pathologically confirmed as EIMS. The patient developed Clavien-Dindo Grade III postoperative complications and was discharged after his condition improved. He received doxorubicin monotherapy after operation, but only one cycle was administered due to severe vomiting. The follow-up of 5 months after operation showed no evidence of recurrence. Given the rarity of EIMS, and ALk inhibitors have a long and robust effect on patients with ALK gene tumors, it is very important for clinicians to be familiar with the clinicopathological features of EIMS, which will contribute to the accurate diagnosis of EIMS and reduce misdiagnosis. Frontiers Media S.A. 2023-09-29 /pmc/articles/PMC10571703/ /pubmed/37841422 http://dx.doi.org/10.3389/fonc.2023.1212529 Text en Copyright © 2023 Dou, Guan, Liu, Zheng, Feng, Wu, Wang and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Dou, Weidong
Guan, Yu
Liu, Tao
Zheng, Hang
Feng, Shuo
Wu, Yingchao
Wang, Xin
Liu, Zhanbing
Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review
title Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review
title_full Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review
title_fullStr Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review
title_full_unstemmed Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review
title_short Epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review
title_sort epithelioid inflammatory myofibroblastic sarcoma: a case report and brief literature review
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571703/
https://www.ncbi.nlm.nih.gov/pubmed/37841422
http://dx.doi.org/10.3389/fonc.2023.1212529
work_keys_str_mv AT douweidong epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview
AT guanyu epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview
AT liutao epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview
AT zhenghang epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview
AT fengshuo epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview
AT wuyingchao epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview
AT wangxin epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview
AT liuzhanbing epithelioidinflammatorymyofibroblasticsarcomaacasereportandbriefliteraturereview